(All fields required)
Please enter a valid email.
Please enter your name.
Kenneth E. Sherman, MD, PhDProfessor and Director Department of Internal Medicine; Division of Digestive Diseases
Dr. Sherman’s research focuses on the interactions of hepatotropic viruses in immunosuppressed hosts. In particular, his laboratory investigates the relationship between hepatitis C virus (HCV) and immunodeficiency virus infection. He uses state of the art molecular techniques that include viral kinetic modeling in different stages of disease progression and the emergence and molecular genotypes of HCV quasi-species analysis in the context of well-defined clinical settings. To explore the underlying mechanisms of host response to a viral insult, he studies cellular and immune correlates of viral evolution. He is also actively involved in translational research utilizing antiviral and immunomodulatory therapies for patients with viral hepatitis.
Dr. Sherman collaborates with Dr. Zucker identifying the association between serum bilirubin levels and the incidence of colorectal cancer. Additionally, Dr. Sherman works with Drs. Blackard and Shata on a clinical intervention trial in HCV/HIV co-infected subjects treated with antiretroviral therapy. Projection of Core use: Biostatistical services.
click image to enlarge
Mean CD4 counts by fibrosis stage grouping (Ishak 1–3 vs 4–6) over period of treatment with pegylated interferon alfa-2a. Error bar represents standard error of mean. No significant difference between observed outcome at any time point or in group comparison. Figure 3 from J Viral Hepat, 2010; 17: 222-226.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462 | TTY:1-513-636-4900
New to Cincinnati Children’s or live outside of the Tristate area? 1-877-881-8479
© 1999-2013 Cincinnati Children's Hospital Medical Center